PhRMA Targets High Cost-Sharing For Drugs In Comments To CMS
Executive Summary
The Pharmaceutical Research and Manufacturers of America is highlighting the negative impact high cost-sharing can have on patient access to drugs, most recently in comments on the draft 2010 "call letter" for Part D plans
You may also be interested in...
Medicare Part D Cost-Sharing Parameters To Be Set By CMS Under Proposal
The Centers for Medicare and Medicaid Services is proposing to set annual limits on drug cost sharing required by Medicare Part D and Medicare Advantage plans, according to a proposed rule released by the agency Oct. 9
Medicare Part D Cost-Sharing Parameters To Be Set By CMS Under Proposal
The Centers for Medicare and Medicaid Services is proposing to set annual limits on drug cost sharing required by Medicare Part D and Medicare Advantage plans, according to a proposed rule released by the agency Oct. 9
Pharma Gets A Friendly Bill: Proposal Would Cut Medicare Rx Copays
A bill being sponsored by Sen. Kay Hutchison, R-Tex., aims to demonstrate that reducing Medicare beneficiaries' cost sharing for prescriptions will increase their adherence to medication therapy